The estimated Net Worth of William Stuart Marshall is at least $6.11 Milione dollars as of 13 February 2018. William Marshall owns over 115,818 units of Miragen Therapeutics Inc stock worth over $6,112,514 and over the last 8 years William sold MGEN stock worth over $0.
Sign up
William Marshall MGEN stock SEC Form 4 insiders trading
William has made over 1 trades of the Miragen Therapeutics Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently William exercised 115,818 units of MGEN stock worth $66,016 on 13 February 2018.
The largest trade William's ever made was exercising 115,818 units of Miragen Therapeutics Inc stock on 13 February 2018 worth over $66,016. On average, William trades about 11,582 units every 0 days since 2017. As of 13 February 2018 William still owns at least 265,646 units of Miragen Therapeutics Inc stock.
You can see the complete history of William Marshall stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's William Marshall's mailing address?
William's mailing address filed with the SEC is C/O MIRAGEN THERAPEUTICS, INC., 6200 LOOKOUT ROAD, BOULDER, CO, 80301.
Insiders trading at Miragen Therapeutics Inc
Over the last 8 years, insiders at Miragen Therapeutics Inc have traded over $636,110 worth of Miragen Therapeutics Inc stock and bought 1,041,411 units worth $5,368,137 . The most active insiders traders include Bennett S Lebow, Bruce Booth e Paul D Rubin. On average, Miragen Therapeutics Inc executives and independent directors trade stock every 91 days with the average trade being worth of $2,345,685. The most recent stock trade was executed by Global Master Fund Lp Logos on 9 November 2020, trading 476,667 units of MGEN stock currently worth $2,268,935.
What does Miragen Therapeutics Inc's logo look like?
Complete history of William Marshall stock trades at Miragen Therapeutics Inc
Miragen Therapeutics Inc executives and stock owners
Miragen Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Diana Escolar,
Chief Medical Officer -
Jason Leverone,
Principal Financial Officer, Principal Accounting Officer, Treasurer, Secretary -
Jeffrey Hatfield,
Independent Chairman of the Board -
Joseph Turner,
Independent Director -
Arlene Morris,
Independent Director -
Christopher Bowden,
Independent Director -
Tomas Kiselak,
Director -
Peter Harwin,
Director -
Lee Rauch,
Chief Executive Officer, Director -
Jonathan Violin,
President, Chief Operating Officer -
Bruce Booth,
Director -
Kyle Lefkoff,
Director -
Paul D Rubin,
EVP, Research & Development -
Adam Scott Levy,
Chief Business Officer -
Thomas E. Hughes,
Director -
Bennett S Lebow,
Director -
Global Master Fund Lp Logos,
10% owner -
John W Creecy,
Director -
Kevin Koch,
Director -
Funds Management Llc Fairmo...,
-
William Stuart Marshall,